IP Library Patent Application 14739985
Patent Application
App. No. 14/739,985

METHODS OF INDUCING AN IMMUNE RESPONSE WITH COMPOSITIONS COMPRISING A NEISSERIA MENINGITIDIS 741 PROTEIN

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
14/739,985
Abstract

Two or more Neisserial proteins are joined such that they are translated as a single polypeptide chain. Hybrid proteins are represented by the formula NH 2 -A-[—X-L-] n -B—COOH where X is an amino acid sequence, L is an optional linker amino acid sequence, A is an optional N-terminal amino acid sequence, B is an optional C-terminal amino acid sequence, and n is an integer greater than 1. Proteins where each of the n-X— moieties shares sequence identity to each other —X— moiety, the protein is a ‘tandem protein’.

Claims (23)

1 . (canceled)

2 . A purified polypeptide comprising (i) an amino acid sequence having at least 80% identity to SEQ ID NO: 3, or (ii) at least 50 consecutive amino acids from SEQ ID NO: 3.

3 . The purified polypeptide of claim 2 , wherein the amino acid sequence has at least 90% identity to SEQ ID NO: 3.

4 . The purified polypeptide of claim 2 , wherein the polypeptide comprises at least 60 consecutive amino acids from SEQ ID NO: 3.

5 . A method of inducing an immune response in a subject comprising administering to the subject an effective amount of a composition comprising the purified polypeptide of claim 2 .

6 . The method of claim 5 , wherein the composition comprises an aluminum salt adjuvant.

7 . The method of claim 6 , wherein the purified polypeptide is adsorbed to the aluminum salt adjuvant.

8 . The method of claim 6 , wherein the aluminum salt adjuvant comprises aluminum phosphate.

9 . The method of claim 7 , wherein the aluminum salt adjuvant comprises aluminum phosphate.

10 . The method of claim 6 , wherein the aluminum salt adjuvant comprises aluminum phosphate.

11 . The method of claim 7 , wherein the aluminum salt adjuvant comprises aluminum phosphate.

12 . A purified protein having formula:

NH2-A-[—X-L-]n-B—COOH

wherein L is an optional linker amino acid sequence, A is an optional N-terminal amino acid sequence, B is an optional C-terminal amino acid sequence, and n is 2 and X is an amino acid sequence comprising at least 40 consecutive amino acids from a 741 protein, wherein the first 741 protein is SEQ ID NO: 3 and the second 741 protein is SEQ ID NO: 7.

13 . A composition comprising the purified protein of claim 12 adsorbed to an aluminum salt adjuvant.

14 . A composition comprising the purified protein of claim 12 and an aluminum hydroxyphosphate adjuvant.

15 . A method of inducing an immune response in a subject comprising administering to the subject an effective amount of a composition comprising the purified polypeptide of claim 12 .

16 . The method of claim 15 , wherein the composition comprises an aluminum salt adjuvant.

17 . The method of claim 16 , wherein the purified polypeptide is adsorbed to the aluminum salt adjuvant.

18 . The method of claim 16 , wherein the aluminum salt adjuvant comprises aluminum phosphate.

19 . The method of claim 17 , wherein the aluminum salt adjuvant comprises aluminum phosphate.

20 . The method of claim 16 , wherein the aluminum salt adjuvant comprises aluminum phosphate.

21 . The method of claim 17 , wherein the aluminum salt adjuvant comprises aluminum phosphate.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 20, 2016
From: NOVARTIS VACCINES AND DIAGNOSTICS SRL
To: GLAXOSMITHKLINE BIOLOGICALS SA
Reel/Frame 040077/0722 →
CHANGE OF NAME Recorded Jun 18, 2015
From: CHIRON S.R.L.
To: NOVARTIS VACCINES AND DIAGNOSTICS S.R.L.
Reel/Frame 035930/0128 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 18, 2015
From: PIZZA, MARIAGRAZIA
To: CHIRON S.R.L.
Reel/Frame 035934/0433 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 18, 2015
From: NOVARTIS VACCINES AND DIAGNOSTICS SRL
To: NOVARTIS AG
Reel/Frame 035977/0640 →